
|Videos|December 16, 2022
Factors for Consideration When Selecting Patients with mCRPC for Treatment With Cabazitaxel
Author(s)Neal Shore, MD, FACS
Neal Shore, MD, FACS, explains the treatment regimen he would have chosen for the patient with mCRPC in the presented case, and what factors he uses to inform treatment decision-making.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD
5












